knowledge exhibiting TGR5 modulation and GLP-1 activation capability, glucose tolerance improvement, preservation for mass and function of pancreatic β-cells, as well as absence of gallbladder filling aspect outcome, represented a promising novel candidate for anti-diabetic drug advancement. Th